These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9152417)

  • 41. Quantitation of human immunodeficiency virus (HIV) with respect to disease stage and zidovudine (AZT) therapy.
    Ved Brat SS; Shepherd LP; Boulberhane A; Pierce PF; Hellman KB
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1271-81. PubMed ID: 1520539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro by carbohydrate-binding agents.
    Balestrieri E; Ascolani A; Igarashi Y; Oki T; Mastino A; Balzarini J; Macchi B
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2771-9. PubMed ID: 18505856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study on anti-HIV-1 activities of composite extract from salvia yunnanensis].
    Peng ZG; Qin DH; Teng L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Aug; 28(8):711-5. PubMed ID: 18928096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of rates of intracellular metabolism of zidovudine in human and primate peripheral blood mononuclear cells.
    Qian M; Chandrasena G; Ho RJ; Unadkat JD
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2398-403. PubMed ID: 7840577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-HIV-1 activity of 3'-azido-3'-deoxythymidine (AZT) in primary mononuclear phagocytes.
    Beenhouwer DO; Rankin JA; Mellors JW
    Antiviral Res; 1992 Jul; 19(1):43-54. PubMed ID: 1444321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined treatments with interferon (alpha,beta) plus PGA1 to control early infection with HTLV-I in primary cord blood-derived mononuclear cells.
    D'Onofrio C; Franzese O; Ricci F; Bonmassar E
    Int J Immunopharmacol; 1993 Feb; 15(2):125-36. PubMed ID: 8468116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human T cell leukaemia virus type 1 p21X mRNA: constitutive expression in peripheral blood mononuclear cells of patients with adult T cell leukaemia.
    Orita S; Takagi S; Saiga A; Minoura N; Araki K; Kinoshita K; Kondo T; Hinuma Y; Igarashi H
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2283-9. PubMed ID: 1402817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiretroviral activity and cytotoxicity of novel zidovudine (AZT) derivatives and the relation to their chemical structure.
    Turk G; Moroni G; Pampuro S; Briñón MC; Salomón H
    Int J Antimicrob Agents; 2002 Oct; 20(4):282-8. PubMed ID: 12385685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits.
    Isono T; Ogawa K; Seto A
    Leuk Res; 1990; 14(10):841-7. PubMed ID: 2259221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
    Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro.
    Balestrieri E; Forte G; Matteucci C; Mastino A; Macchi B
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3080-3. PubMed ID: 12183277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A critical analysis of the pharmacology of AZT and its use in AIDS.
    Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Causer D; Alphonso H; Miller T
    Curr Med Res Opin; 1999; 15 Suppl 1():S1-45. PubMed ID: 11594171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells.
    Rooke R; Tremblay M; Wainberg MA
    Virology; 1990 May; 176(1):205-15. PubMed ID: 1691885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Restoration of the antiviral activity of 3'-azido-3'-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus by delivery of engineered thymidylate kinase to T cells.
    Lavie A; Su Y; Ghassemi M; Novak RM; Caffrey M; Sekulic N; Monnerjahn C; Konrad M; Cook JL
    J Gen Virol; 2008 Jul; 89(Pt 7):1672-1679. PubMed ID: 18559937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-acetyl-cysteine and L-2-oxothiazolidine-4-carboxylic acid enhance contact-dependent growth of HIV in resting peripheral blood mononuclear cells (PBMC) in vitro and increase recovery of HIV from human-PBMC SCID mice.
    Chen P; Bauer G; Mitchell J; Factor R; Markham R; Schwartz DH
    AIDS; 1997 Jan; 11(1):33-41. PubMed ID: 9110073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of human immunodeficiency virus type 1 multiplication by transforming growth factor beta 1 and AZT in HIV-1-infected myeloid cells.
    McKiel V; Gu Z; Wainberg MA; Hiscott J
    J Interferon Cytokine Res; 1995 Oct; 15(10):849-55. PubMed ID: 8564706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo.
    Nakashima H; Tochikura T; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
    Virology; 1987 Jul; 159(1):169-73. PubMed ID: 3111083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.
    Lambert DM; Bartus H; Fernandez AV; Bratby-Anders C; Leary JJ; Dreyer GB; Metcalf BW; Petteway SR
    Antiviral Res; 1993 Aug; 21(4):327-42. PubMed ID: 7692816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sodium pentosan polysulfate (PPS), an anti-HIV agent also exhibits synergism with AZT, lymphoproliferative activity, and virus enhancement.
    Anand R; Nayyar S; Galvin TA; Merril CR; Bigelow LB
    AIDS Res Hum Retroviruses; 1990 May; 6(5):679-89. PubMed ID: 1694454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT.
    Williams GJ; Colby CB
    J Interferon Res; 1989 Dec; 9(6):709-18. PubMed ID: 2514233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.